Memory-related experiments
A mouse study reported changes in cognitive measures in a disease model. It did not test treatment in people.
Read the publication
Physician-led care in the UAE
Peptide care · Capsules
Dihexa
An independent mouse study reported cognitive findings. Human benefits remain unestablished, and a prominent earlier mechanistic paper was retracted.
- Discuss your health goals and suitability with a physician
- Your prescribed preparation is confirmed during care
- Clinical review and follow-up guide the next steps
Select the format
Get startedImportant safety informationSuitability reviewed by a UAE-licensed physician
Confirm the dispensing pharmacy and preparation before treatment
Completing an assessment does not guarantee a prescription
Formats reflect the supplied catalog, not a prescription or confirmation of availability. Health topics describe scientific interest, not approved indications. Read the specific studies and preparation limits.
The role of this peptide
Where Dihexa
has been studied.
Included under cognition because of animal experiments. There is no established human memory, focus or sleep benefit in the reviewed sources.
Confidence in the evidence
A prominent earlier mechanism paper was retracted. It is excluded from the supporting evidence and should not strengthen claims about Dihexa.
Read the publicationSafety & suitability
Is Dihexa right for you?
Without reliable human trials, clinical benefit and safety remain uncertain. Retractions also limit confidence in parts of the earlier literature.
Suitability depends on the specific preparation, intended use and clinical assessment. Product authorization must be verified separately from facility licensing.
The evidence
Dihexa:
what has been studied.
The supporting work is in animals, not people. Human memory benefits remain unestablished. A retracted mechanism paper is excluded from supporting evidence.
The study reported improvements in cognitive measures in the mouse model.
APP/PS1 mouse model · Experimental treatment
What remains uncertain
Read the studyA disease-model mouse study cannot establish human memory improvement or safe use.
The notice identifies an earlier paper that should not be used as supporting evidence.
Not a treatment study · Not applicable
What remains uncertain
Read the studyA retracted paper must not be counted as a positive finding or used to strengthen a mechanism claim.
About this evidence review
Animal experiments do not establish the effectiveness of oral capsules in people. The retracted 2014 mechanism paper is excluded from supportive evidence.
Reviewed September 15, 2026. Selected publications, not a systematic review. Findings do not establish product authorization.
Our review approachFor your consultation
Know what to ask.
Three questions to help you discuss Dihexa. Your clinician decides which preparation, checks and follow-up are relevant.
01
The preparation
What exactly are we considering?
What do the listed 2.5 mg and 20 mg strengths mean, given that human benefit and safety have not been established?
02
Your assessment
What needs checking first?
What baseline assessment is appropriate given the limited human evidence?
03
Your follow-up
How will we review the plan?
What should I record about sleep, daytime function and any changes before our review?
These questions are not a dosing schedule or a required test panel. Your clinician individualizes the plan.
A considered approach
to peptide care.
A peptide name is only the beginning. The preparation, clinical need and available evidence all matter to the decision.
Dr. Sami Mohammed Yesuf, MD
Medical Director & Physician, DarDoc
Dr. Marwa Abuaita, MD
Physician, DarDoc
- 01
Start with the clinical question
Discuss the symptoms or diagnosis behind your interest in a peptide, alongside current medicines and previous treatment.
- 02
Review the exact preparation
Consider the evidence for its route and intended use, its regulatory status, and established treatment alternatives.
- 03
Make an informed decision
Discuss potential benefits, uncertainties and risks. A prescription is considered only when clinically appropriate and permitted.
- 04
Agree how to review progress
If treatment is prescribed, agree on monitoring, side effects to report and when to reassess the plan.
SCOPE credentials shown relate to obesity medicine, not peptide-specific certification. The treating physician is confirmed at booking.
A few things to know
Your questions,
answered.
How is Dihexa considered in a consultation?
Your physician reviews your symptoms, history, current medicines and goals. The discussion should include the specific evidence, risks, alternatives and a follow-up plan before any treatment decision.
Which Dihexa format is right for me?
Animal experiments do not establish the effectiveness of oral capsules in people. The retracted 2014 mechanism paper is excluded from supportive evidence.
What should I know about the safety of Dihexa?
Without reliable human trials, clinical benefit and safety remain uncertain. Retractions also limit confidence in parts of the earlier literature.
Can I order without a consultation?
Prescription treatment is considered only after clinical assessment. Browsing a format does not select a dose, determine eligibility or guarantee a prescription.
Continue exploring
More in this area.
Explore other compounds discussed in these health topics, with the evidence for each.
DarDoc peptidesHealthy aging · Sleep & focus
Epitalon
Cell studies examine telomerase activity. An older clinical report explored a retinal condition, but human longevity benefits remain unestablished.
DarDoc peptidesSleep & focus
DSIP
Small placebo-controlled insomnia studies produced mixed findings. They do not establish a reliable treatment effect.
DarDoc peptidesSleep & focus
Semax
Human work has explored recovery after ischemic stroke and brain-connectivity measures, rather than everyday concentration.
Bring your questions
Make your next step
a conversation.
Want to understand where Dihexa fits? Discuss the evidence, your health history and the options with DarDoc.
